La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Deveron Bilan de santé

Santé financière contrôle des critères 2/6

Deveron possède un total de capitaux propres de CA$29.2M et une dette totale de CA$44.0M, ce qui porte son ratio d'endettement à 150.9%. Son actif total et son passif total sont CA$102.5M et de CA$73.3M.

Informations clés

150.9%

Ratio d'endettement

CA$43.99m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	CA$1.09m
Fonds propres	CA$29.15m
Total du passif	CA$73.30m
Total des actifs	CA$102.45m

Mises à jour récentes de la santé financière

Is Deveron (CVE:FARM) A Risky Investment?

Nov 24

Is Deveron (CVE:FARM) Using Too Much Debt?

Aug 23

Recent updates

Deveron Corp. (CVE:FARM) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jun 20

Deveron Corp. (CVE:FARM) Might Not Be As Mispriced As It Looks After Plunging 26%

May 03

CA$1.33: That's What Analysts Think Deveron Corp. (CVE:FARM) Is Worth After Its Latest Results

Nov 25

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de FARM ( CA$5.6M ) ne couvrent pas ses passifs à court terme ( CA$14.5M ).

Passif à long terme: Les actifs à court terme de FARM ( CA$5.6M ) ne couvrent pas ses passifs à long terme ( CA$58.8M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de FARM ( 147.1% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de FARM est passé de 0% à 150.9% au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: Bien que non rentable FARM dispose d'une piste de trésorerie suffisante pour plus de 3 ans si elle maintient son niveau actuel de flux de trésorerie disponible positif.

Prévisions de trésorerie: FARM n'est pas rentable mais dispose d'une marge de trésorerie suffisante pour plus de 3 ans, même avec un flux de trésorerie disponible positif et en baisse de 22.6 % par an.

Deveron Bilan de santé

Santé financière contrôle des critères 2/6

Informations clés

Mises à jour récentes de la santé financière

Is Deveron (CVE:FARM) A Risky Investment?

Is Deveron (CVE:FARM) Using Too Much Debt?

Recent updates

Less than half of directors are independent

Deveron Corp. announced that it has received CAD 3.13581 million in funding

Deveron Corp. announced that it expects to receive CAD 3 million in funding

New minor risk - Shareholder dilution

Deveron Corp. (CVE:FARM) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Third quarter 2024 earnings released: CA$0.025 loss per share (vs CA$0.042 loss in 3Q 2023)

New major risk - Market cap size

Deveron Corp. to Report Q3, 2024 Results on May 28, 2024

Deveron Corp., Annual General Meeting, Jul 25, 2024

Deveron Corp. (CVE:FARM) Might Not Be As Mispriced As It Looks After Plunging 26%

Deveron Corp. announced that it has received CAD 0.575 million in funding

Second quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.03 profit in 2Q 2023)

Deveron Corp. to Report Q2, 2024 Results on Feb 21, 2024

Deveron Passes 2-Stage Pilot and Onboards New Pfas Enterprise Customer

New major risk - Share price stability

Investors Continue Waiting On Sidelines For Deveron Corp. (CVE:FARM)

Independent Non Executive Chairman recently bought CA$204k worth of stock

Is Deveron (CVE:FARM) A Risky Investment?

Deveron Corp. to Report Q1, 2024 Results on Nov 21, 2023

Full year 2023 earnings released: CA$0.19 loss per share (vs CA$0.12 loss in FY 2022)

Deveron Corp. to Report Q4, 2023 Results on Oct 26, 2023

Deveron Corp. announced that it expects to receive CAD 2 million in funding

Deveron Corp. Announces CFO Changes

Deveron Corp. Provides Revenue Guidance for the Fourth Quarter Ending June 30, 2023

Deveron Corp. Provides Revenue Guidance for the Fourth Quarter Ending June 30, 2023

Is Deveron (CVE:FARM) Using Too Much Debt?

Price target decreased by 14% to CA$0.92

First quarter 2023 earnings released: CA$0.042 loss per share (vs CA$0.037 loss in 1Q 2022)

Deveron Corp. to Report Q1, 2023 Results on May 30, 2023

Deveron Corp., Annual General Meeting, Jun 27, 2023

Director recently bought CA$750k worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Deveron Corp. Announces Retirement of Jim Pirie from Board of Directors, Effective January 1, 2023

Consensus EPS estimates fall by 30%

Independent Non Executive Chairman exercised options to buy CA$110k worth of stock.

CA$1.33: That's What Analysts Think Deveron Corp. (CVE:FARM) Is Worth After Its Latest Results

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Deveron Corp. Appoints Tim Close as New Board Member

Independent Non Executive Chairman exercised options to buy CA$204k worth of stock.

No longer forecast to breakeven

Deveron Corp. to Report Q3, 2022 Results on Nov 21, 2022

Deveron Corp. (TSXV:FARM) completed the acquisition of Assets of Frontier Labs Inc.

Deveron Corp. announced that it has received CAD 2.7 million in funding from Coeli Wealth Management AB

Deveron Corp. announced that it has received CAD 2.7 million in funding from Coeli Wealth Management AB

Deveron Corp. (TSXV:FARM) has completed a Letter of Intent to acquire Assets of Frontier Labs Inc on September 20, 2022.

Deveron Corp. announced that it expects to receive $1.5 million in funding from Coeli Wealth Management AB

No longer forecast to breakeven

Deveron Corp. to Report Q2, 2022 Results on Aug 22, 2022

Deveron Corp. (TSXV : FARM) completed the acquisition of Assets of Agri-Labs, Inc. for $1.2 million.

Deveron Corp. (TSXV:FARM) acquired 67% stake in A&L Canada Laboratories Inc. from certain vendor shareholders including Greg Patterson, CEO of A&L.

Deveron Corp. (TSXV:FARM) acquired 67% stake in A&L Canada Laboratories Inc. from certain vendor shareholders including Greg Patterson, CEO of A&L.

Deveron Corp. announced that it has received CAD 10 million in funding

Deveron Corp. announced that it expects to receive CAD 10 million in funding

Deveron Corp. (TSXV:FARM) entered into a definitive agreement to acquire a 67% stake in A&L Canada Laboratories Inc. from certain vendor shareholders including Greg Patterson, CEO of A&L, for CAD 50.3 million.

Deveron Corp., Annual General Meeting, Jun 28, 2022

Deveron Corp. has completed a Composite Units Offering in the amount of CAD 10 million.

Deveron Corp. Launches of Its Agricultural Carbon Services Platform

Deveron Corp. (TSXV:FARM) entered into an agreement to acquire Assets of Agronomic Solutions, LLC. from Agronomic Solutions, LLC for $1.1 million.

Deveron Corp. (TSXV:FARM) completed the acquisition of assets of Stealth Ag Inc.

Deveron Corp. announced that it has received CAD 8.207583 million in funding

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines